Dr. Ryan Cole: “The CEO [of Pfizer] in an interview a few weeks ago, said, ‘Well, I was even surprised [that we went this route].’ We’ve only been working on mRNA technology for about two years, and when the lead scientist said, ‘We’re going with this because it’s faster and easier to make.’ It wasn’t … Continue reading ‘An Unnecessary Shot’: Pharma Prioritizes Convenience Over Safety for a Demographic Not at Risk